NCT00419328 2022-07-21
A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors
AGC Biologics S.p.A.
Phase 1 Completed
Clinical Trials
5 trialsNCT01098266 2019-09-17
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
AGC Biologics S.p.A.
Phase 3 Completed
NCT00484276 2019-01-16
NGR010
AGC Biologics S.p.A.
Phase 2 Completed
NCT01358084 2019-01-15
NGR019
AGC Biologics S.p.A.
Phase 2 Completed
NCT00483093 2014-05-30
Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor
AGC Biologics S.p.A.
Phase 1 Completed